GLP-1 ( )
The results of cardiovascular outcome trials (CVOTs) in people with type 2 diabetes mellitus and increased cardiovascular risk have demonstrated a significant benefit in terms of reduction in time to first major adverse cardiovascular event (MACE) with the use of liraglutide, semaglutide, albiglutide and dulaglutide [15]
Rangaraju S, Gearing M, Jin L-W, Levey A (2015) Potassium channel K V 1.3 is highly expressed by microglia in human Alzheimers disease
I'm humbled about what we have done, said Qeadan
It causes several symptoms including acute and chronic pelvic pain, dysmenorrhea, dyspareunia, abnormal vaginal bleeding, infertility/sterility, and, in severe stages, gastrointestinal and urological symptoms
Increased urination, another reported side effect, may also contribute to fluid loss